Posted Jun. 20, 2013 at 3:18 p.m.

Premium Lock GSK teams with French VC firm in $58M fund targeting rare diseases

Published: 2013-06-20 15:18:31
Updated: 2013-06-20 15:18:31

Print this blog post

Kurma Life Science Partners says its new fund is the first one focused on financing and developing new drugs for so called "orphan" diseases....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa